Prognostic signiicance of VEGF and its receptors in endometrioid endometrial cancer;Znaczenie prognostyczne VEGF i jego receptorów w raku endometrium typu endometrioidalnego

Ginekologia Polska

Volumn 81, Issue 6, 2010, Pages 422-425

  Bozena, Dobrzycka ^a   Jerzy, Terlikowski Sławomir ^a   Marcin, Kwiatkowski ^a   Magdalena, Garbowicz ^a   Maciej, Kinalski ^b   Lech, Chyczewski ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b District General Hospital Bialystok   (Poland)

Author keywords

Disease free survival; Endometrial cancer; VEGF; VEGFR 1; VEGFR 2

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; POLAND; PROGNOSIS; SURVIVAL;

AGED; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POLAND; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77954552979     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res. 2001, 21(6B), 4383-4288.
2. Krikun G, Schatz F, Lockwood CJ. Endometrial angiogenesis: from physiology to pathology. Ann N Y Acad Sci. 2004, 1034, 27-35.
3. Rogers P, Donoghue J, Walter L, [et al.]. Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci. 2009, 16, 147-151.
4. Girling J, Rogers P. Recent advances in endometrial angiogenesis research. Angiogenesis. 2005, 8, 89-99.
5. Stuttfeld E, Ballmer-Hofer K. Structure and function of VEGF receptors. IUBMB Life. 2009, 61, 915-922.
6. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005, 69, suppl 3, 4-10.
7. Rasila K, Burger R, Smith H, [et al.]. Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer. 2005, 15, 710-726.
8. Abulaia O, Triest W, Sherer D. Angiogenesis in malignancies of the female genital tract. Gynecol Oncol. 1999, 72,:220-231.
9. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer Pediatr Oncol. 1997, 74, 64-68.
10. Horner M, Ries L, Krapcho M, [et al.]. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
11. Reports based on data of National Cancer Registry. The Maria Sklodowska - Curie memorial Cancer Center, Department of Epidemiology and Cancer Prevetion. National Cancer Registry 2004, http://epid.coi.waw.pl/krn.
12. Hall K, Ran S. Regulation of tumor angiogenesis by the local environment. Front Biosci. 2010, 15, 195-212.
13. Dobrzycka B, Kinalski M, Piechocka D, [et al.]. The role of estrogens in angiogenesis in the female reproductive system. Endokrynol Pol. 2009, 60, 210-214. Polish.
14. Bamberger E, Perrett C. Angiogenesis in benign, pre-malignant and malignant vulvar lesions. Anticancer Res. 2002, 22 (6C), 3853-3865.
15. Mazurek A, Kuc P, Terlikowski S, [et al.]. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer. Neoplasma. 2006, 53, 242-246.
16. Smerdel M, Waldstrøm M, Brandslund I, [et al.]. Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer. Int J Gynecol Cancer. 2009, 19, 578-584.
17. Terlikowski S, Lenczewski A, Sulkowska M, [et al.]. Tissue expression of VEGF as a prognostic factor in early cervical squamous cell carcinoma. Folia Histochem Cytobiol. 2001, 39, Suppl 2,195-196.